公司资料
Omeros 股价、新闻与催化剂
- 股票代码:
- OMER
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
19.32 USD (+0.26%)
收盘价
最后更新: 2026年8月24日
743M USD
市值
股价为何变动
As of Aug 24, 2026, OMER closed up 0.26% at $19.32. No new same-company headline was identified in the current news window.
公司概览
业务概览
Omeros is a biotechnology company with programs in immunology, complement biology, and rare disease. The company has long been defined by a mix of scientific ambition and a complicated commercial path.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Omeros sits in specialty biotechnology.
商业模式特征
The business depends on clinical validation, portfolio management, and the ability to unlock value from a narrow set of programs.
生物医药行业定位
Omeros is a high-uncertainty biotech name whose valuation is driven by pipeline outcomes and strategic progress.
未来催化剂
- Omeros’s catalysts are narsoplimab and the remaining complement / immunology assets. Investors will focus on whether the company can still turn its late-stage biology into something commercially relevant.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。